• Login
    ARAN - Access to Research at NUI Galway
    View Item 
    •   ARAN Home
    • Support Services
    • Externally hosted open access publications with NUI Galway authors (2)
    • View Item
    •   ARAN Home
    • Support Services
    • Externally hosted open access publications with NUI Galway authors (2)
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ARANCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsTypesThis CollectionBy Issue DateAuthorsTitlesSubjectsTypes

    My Account

    LoginRegister

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Help

    How to submit and FAQs

    Cytokine treatment optimises the immunotherapeutic effects of umbilical cord-derived msc for treatment of inflammatory liver disease

    Thumbnail
    View/Open
    Full Text
    Date
    2017-06-08
    Author
    de Witte, Samantha F. H.
    Merino, Ana M.
    Franquesa, Marcella
    Strini, Tanja
    van Zoggel, Johanna A. A.
    Korevaar, Sander S.
    Luk, Franka
    Gargesha, Madhu
    O’Flynn, Lisa
    Roy, Debashish
    Elliman, Steve J.
    Newsome, Philip N.
    Baan, Carla C.
    Hoogduijn, Martin J.
    Metadata
    Show full item record
    Usage
    This item's downloads: 0 (view details)
    Cited 30 times in Scopus (view citations)
    
    Recommended Citation
    de Witte, Samantha F. H. Merino, Ana M.; Franquesa, Marcella; Strini, Tanja; van Zoggel, Johanna A. A.; Korevaar, Sander S.; Luk, Franka; Gargesha, Madhu; O’Flynn, Lisa; Roy, Debashish; Elliman, Steve J.; Newsome, Philip N.; Baan, Carla C.; Hoogduijn, Martin J. (2017). Cytokine treatment optimises the immunotherapeutic effects of umbilical cord-derived msc for treatment of inflammatory liver disease. Stem Cell Research & Therapy 8 ,
    Published Version
    https://stemcellres.biomedcentral.com/track/pdf/10.1186/s13287-017-0590-6?site=stemcellres.biomedcentral.com
    Abstract
    Background: Mesenchymal stromal cells (MSC) possess immunomodulatory properties and low immunogenicity, both crucial properties for their development into an effective cellular immunotherapy. They have shown benefit in clinical trials targeting liver diseases; however the efficacy of MSC therapy will benefit from improvement of the immunomodulatory and immunogenic properties of MSC. Methods: MSC derived from human umbilical cords (ucMSC) were treated for 3 days in vitro with various inflammatory factors, interleukins, vitamins and serum deprivation. Their immunogenicity and immunomodulatory capacity were examined by gene-expression analysis, surface-marker expressions, IDO activity, PGE(2) secretion and inhibition of T cell proliferation and IFN gamma production. Furthermore, their activation of NK cell cytotoxicity was investigated via CD107a expression on NK cells. The immunomodulatory capacity, biodistribution and survival of pre-treated ucMSC were investigated in a CCl4-induced liver disease mouse model. In addition, capacity of pre-treated MSC to ameliorate liver inflammation was examined in an ex vivo liver inflammation co-culture model. Results: IFN-gamma and a multiple cytokine cocktail (MC) consisting of IFN-gamma, TGF beta and retinoic acid upregulated the expression of immunomodulatory factor PD-L1 and IDO activity. Subsequently, both treatments enhanced the capacity of ucMSC to inhibit CD4 and CD8 T cell proliferation and IFN-gamma production. The susceptibility of ucMSC for NK cell lysis was decreased by IFN-beta, TGF beta and MC treatment. In vivo, no immunomodulation was observed by the ucMSC. Four hours after intravenous infusion in mice with CCl4-induced inflammatory liver injury, the majority of ucMSC were trapped in the lungs. Rapid clearance of ucMSC(VitB(6)), ucMSC(Starv + VitB(6)) and ucMSC(MC) and altered bio-distribution of ucMSC(TGF beta) compared to untreated ucMSC was observed. In the ex vivo co-culture system with inflammatory liver slices ucMSC(MC) showed significantly enhanced modulatory capacity compared to untreated ucMSC. Conclusions: The present study demonstrates the responsiveness of ucMSC to in vitro optimisation treatment. The observed improvements in immunomodulatory capacity as well as immunogenicity after MC treatment may improve the efficacy of ucMSC as immunotherapy targeted towards liver inflammation.
    URI
    http://hdl.handle.net/10379/11109
    Collections
    • Externally hosted open access publications with NUI Galway authors (2)
    • Copyright @ NUI Galway
    • Library
    • NUI Galway